High Expression of <i>PKCζ</i> and <i>ALDH1A3</i> Is Associated With Poor Prognosis in Luminal B Breast Cancer
<i>PKCζ</i> may be involved in the progression of ALDH1A3-positive luminal B breast cancer. Furthermore, <i>PKCζ</i> and <i>ALDH1A3</i> could serve as molecular targets and prognostic biomarkers for predicting the efficacy of endocrine therapy in patients with ALDH1A3 positive luminal B breast cancer.
Authors
- Kazunori Akimoto (ORCID: https://orcid.org/0000-0003-0618-1765)
- Shoma Tamori
- Takahiro Kasai
- Kazunori Sasaki (ORCID: https://orcid.org/0000-0002-3050-6331)
- Shigeo Ohno (ORCID: https://orcid.org/0000-0002-1294-5269)
- Yuka Nagashima
- Yuki Maemura
- Ayaka Ozaki
- Ryosuke Chiwaki
- Kana Nohata
Institutions
- Tokyo University of Pharmacy and Life Sciences (JP)
- Tokyo University of Science (JP)
- Juntendo University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17785
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Promotion and Mutual Aid Corporation for Private Schools of Japan
- Moonshot Research and Development Program